- News & Features
New research, published by the Centers for Disease Control and Prevention, indicates that arthritis patients aren’t receiving sufficient counseling about weight loss.
Ultrasound and MRI have been shown to be more sensitive than clinical examination in detecting synovitis, both in active disease and in remission.
Younger, thinner rheumatoid arthritis patients, with lower disease activity and better scores on a certain health assessment, have a better chance of achieving remission when combining the tumor-necrosis factor (TNF) inhibitor etanercept (enbrel) with methotrexate induction therapy.
Ever wonder what life is like for those living chronic and invisible diseases? Learn about the invisible struggles people with chronic disease face.
Higher MBDA scores yielded statistically significant associations with higher serious infection rates and significantly higher rates of heart disease.
On Dec. 14, Pfizer, which makes tofacitinib (Xeljanz), announced that the FDA had approved the drug for PsA.
In 2017, CreakyJoints lived up to our mantra of “bringing arthritis to its knees", by increasing support, education, advocacy, and research activities.
These findings suggest that there is a window of opportunity to treat patients with undifferentiated arthritis early, to delay subsequent progression to RA.
FDA is investigating serious adverse events involving Limbrel, a product in capsule form currently being marketed as a medical food to manage the metabolic processes associated with osteoarthritis.
Adults with hypertension can lower their blood pressure by consuming less sodium and sticking to the Dietary Approaches to Stop...
More than half of cardiovascular disease patients are being denied access to a new treatment.